PB1999: ATG-010 PLUS LOW-DOSE DEXAMETHASONE (SD) IN CHINESE RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) PATIENTS PREVIOUSLY RECEIVED CHIMERIC ANTIGEN RECEPTOR T-CELL (CAR-T)

• W. Fu,
• Z. Xia,
• C. Fu,
• W. Chen,
• C. Chang,
• B. Fang,
• G. An,
• Y. Wei,
• Z. Cai,
• S. Gao,
• J. Weng,
• L. Chen,
• H. Jing,
• F. Li,
• Z. Liu,
• X. Chen,
• J. Liu,
• Y. Yu,
• A. Wang,
• Y. Fei,
• L. Qiu

Affiliations

W. Fu

1 Shangai Changzheng Hospital, Shanghai

Z. Xia

2 Sun Yat-sen University Cancer Center, Guangzhou

C. Fu

3 The First Affiliated Hospital of Soochow University, Suzhou

W. Chen

4 Beijing Chaoyang Hospital, Beijing

C. Chang

5 Shanghai Jiao Tong University Affiliated Sixth People’s Hospital, Shanghai

B. Fang

6 Henan Cancer Hospital, Zhengzhou

G. An

7 Institute of Hematology and Blood Diseases Hospital, Tianjin

Y. Wei

8 Nanfang Hospital, Guangzhou

Z. Cai

9 The First Affiliated Hospital,Zhejiang University School of Medicine, Hangzhou

S. Gao

10 the First Affiliated Hospital of Jilin University, Changchun

J. Weng

11 Guangdong Provincial People’s Hospital, Guangzhou

L. Chen

12 Jiangsu Province Hospital, First Affiliated Hospital of Nanjing Medical University, Nanjing

H. Jing

13 Peking University Third Hospital, Beijing

F. Li

14 the First Affiliated Hospital of Nanchang University, Nanchang

Z. Liu

15 Shengjing Hospital of China Medical University, Shenyang

X. Chen

16 Xi Jing Hospital affiliated to the Fourth Military Medical University, Xi’An

J. Liu

17 the Third Xiangya Hospital of Central South University, Changsha

Y. Yu

18 Antengene Therapeutics Ltd., Shanghai, China

A. Wang

18 Antengene Therapeutics Ltd., Shanghai, China

Y. Fei

18 Antengene Therapeutics Ltd., Shanghai, China

L. Qiu

7 Institute of Hematology and Blood Diseases Hospital, Tianjin